Annual Retained Earnings
-$59.54 M
-$15.19 M-34.25%
December 31, 2023
Summary
- As of February 7, 2025, VRPX annual retained earnings is -$59.54 million, with the most recent change of -$15.19 million (-34.25%) on December 31, 2023.
- During the last 3 years, VRPX annual retained earnings has fallen by -$48.90 million (-459.22%).
- VRPX annual retained earnings is now -1883.68% below its all-time high of -$3.00 million, reached on December 31, 2018.
Performance
VRPX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$68.22 M
-$2.01 M-3.03%
September 30, 2024
Summary
- As of February 7, 2025, VRPX quarterly retained earnings is -$68.22 million, with the most recent change of -$2.01 million (-3.03%) on September 30, 2024.
- Over the past year, VRPX quarterly retained earnings has dropped by -$13.24 million (-24.08%).
- VRPX quarterly retained earnings is now -981.47% below its all-time high of -$6.31 million, reached on December 31, 2019.
Performance
VRPX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
VRPX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.3% | -24.1% |
| 3 y3 years | -459.2% | -267.1% |
| 5 y5 years | -1883.7% | -267.1% |
VRPX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -162.3% | at low | -200.5% | at low |
| 5 y | 5-year | -843.9% | at low | -981.5% | at low |
| alltime | all time | -1883.7% | at low | -981.5% | at low |
Virpax Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$68.22 M(+3.0%) |
| Jun 2024 | - | -$66.21 M(+5.5%) |
| Mar 2024 | - | -$62.76 M(+5.4%) |
| Dec 2023 | -$59.54 M(+34.2%) | -$59.54 M(+8.3%) |
| Sep 2023 | - | -$54.98 M(+12.2%) |
| Jun 2023 | - | -$48.99 M(+6.8%) |
| Mar 2023 | - | -$45.88 M(+3.4%) |
| Dec 2022 | -$44.35 M | -$44.35 M(+7.2%) |
| Sep 2022 | - | -$41.37 M(+22.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -$33.73 M(+21.1%) |
| Mar 2022 | - | -$27.84 M(+22.6%) |
| Dec 2021 | -$22.70 M(+113.2%) | -$22.70 M(+22.2%) |
| Sep 2021 | - | -$18.59 M(+20.9%) |
| Jun 2021 | - | -$15.37 M(+18.0%) |
| Mar 2021 | - | -$13.03 M(+22.3%) |
| Dec 2020 | -$10.65 M(+68.8%) | -$10.65 M(+7.1%) |
| Sep 2020 | - | -$9.94 M(+57.6%) |
| Dec 2019 | -$6.31 M(+110.2%) | -$6.31 M |
| Dec 2018 | -$3.00 M | - |
FAQ
- What is Virpax Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals annual retained earnings year-on-year change?
- What is Virpax Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly retained earnings year-on-year change?
What is Virpax Pharmaceuticals annual retained earnings?
The current annual retained earnings of VRPX is -$59.54 M
What is the all time high annual retained earnings for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high annual retained earnings is -$3.00 M
What is Virpax Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, VRPX annual retained earnings has changed by -$15.19 M (-34.25%)
What is Virpax Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of VRPX is -$68.22 M
What is the all time high quarterly retained earnings for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high quarterly retained earnings is -$6.31 M
What is Virpax Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, VRPX quarterly retained earnings has changed by -$13.24 M (-24.08%)